Kenneth Truitt
Geen lopende functies
Profiel
Kenneth Truitt served as Chief Medical Officer at Aquestive Therapeutics, Inc., ImmusanT, Inc., and Venthera, Inc.
Eerdere bekende functies van Kenneth Truitt
Bedrijven | Functie | Einde |
---|---|---|
Venthera, Inc.
Venthera, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Venthera, Inc. develops biopharmaceuticals. The company is based in Palo Alto, CA. The company was founded by José Baselga. | Hoofd Techniek/Wetenschap/O&O | - |
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | - |
AQUESTIVE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AQUESTIVE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Venthera, Inc.
Venthera, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Venthera, Inc. develops biopharmaceuticals. The company is based in Palo Alto, CA. The company was founded by José Baselga. | Health Technology |
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Health Technology |